News

Pharmaceutical major Wockhardt is targeting a “very healthy bottom line” in the coming quarters, following its exit from the ...
Trump’s main effort, which he cited on August 3, centers on getting drugmakers to offer the same price in the US as they do ...
A California jury found that Meta was “eavesdropping” in women’s health data. This decision has implications on the future of health privacy.
ASX-listed Nanosonics, Optiscan, and Clever Culture Systems are transforming healthcare and pharmaceutical development efficiency through innovative devices. ... Read More The post Faster, smarter, ...
Kasey Raetz, Pharm.D., transitioned from working at a small independent pharmacy to leading product and pharma contracting strategy at Express Scripts, earning a PBMI Innovator Award for her creative ...
In the final part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, ...
OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 million.
Analysts are estimating that Liquidia will report an earnings per share (EPS) of $-0.41. The market awaits Liquidia's announcement, with hopes high for news of surpassing estimates and providing ...
The global Health Care industry has steeply underperformed regional equity indices over the last two years and notably since ...
Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...